Inhibikase Therapeutics
IKT
IKT
11 hedge funds and large institutions have $1.12M invested in Inhibikase Therapeutics in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$48K | |
| 2 | +$16.6K | |
| 3 | +$13K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.33K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$14 |
Top Sellers
| 1 | -$49.6K | |
| 2 | -$2.18K | |
| 3 | -$1.17K | |
| 4 |
MG
Mather Group
Chicago,
Illinois
|
-$721 |